Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 2938-2949

  Gorantla, Santhi ^a   Makarov, Edward ^a   Finke Dwyer, Jennifer ^a   Castanedo, Antonio ^a   Holguin, Adelina ^a,c   Gebhart, Catherine L ^b   Gendelman, Howard E ^a,b   Poluektova, Larisa ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; DISEASE COURSE; ENCEPHALITIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION;

EID: 78650217622     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100536     Document Type: Article

References (90)

1. Persidsky Y, Limoges J, McComb R, Bock P, Baldwin T, Tyor W, Patil A, Nottet HSLM, Epstein L, Gelbard H, Flanagan E, Reinhard J, Pirruccello SJ, Gendelman HE: Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol 1996, 149:1027-1053 (Pubitemid 26334186)
2. Persidsky Y, Buttini M, Limoges J, Bock P, Gendelman HE: An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J Neurovirol 1997, 3:401-416
3. Poluektova LY, Munn DH, Persidsky Y, Gendelman HE: Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol 2002, 168:3941-3949
4. Poluektova L, Gorantla S, Faraci J, Birusingh K, Dou H, Gendelman HE: Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. J Immunol 2004, 172:7610-7617 (Pubitemid 38747625)
5. Tyor WR, Power C, Gendelman HE, Markham RB: A model of human immunodeficiency virus encephalitis in scid mice. Proc Natl Acad Sci USA 1993, 90:8658-8662
6. Poluektova L, Meyer V, Walters L, Paez X, Gendelman HE: Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis. Glia 2005, 52:344-353
7. Gorantla S, Makarov E, Finke-Dwyer J, Gebhart CL, Domm W, Dewhurst S, Gendelman HE, Poluektova LY: CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. J Immunol 2010, 184:7082-7091
8. Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, Dewan MZ, Yu Z, Ito M, Morio T, Shimizu N, Honda M, Yamamoto N: Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007, 109:212-218 (Pubitemid 46070123)
9. Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, Mugishima H, Fujiwara S, Shimizu K, Honda M, Shimizu N, Yamamoto N: Humanized NOD/SCID/IL2R{gamma}null mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol 2007, 81:13259-13264
10. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T: NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175-3182
11. Baenziger S, Tussiwand R, Schlaepfer E, Mazzucchelli L, Heikenwalder M, Kurrer MO, Behnke S, Frey J, Oxenius A, Joller H, Aguzzi A, Manz MG, Speck RF: Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci USA 2006, 103:15951-15956
12. Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, West JT, Wood C, Dewhurst S, Gendelman HE, Poluektova L: Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J Virol 2007, 81:2700-2712
13. Berges B, Akkina S, Folkvord J, Connick E, Akkina R: Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice. Virology 2008, 373:342-351
14. An DS, Poon B, Fang RH, Weijer K, Blom B, Spits H, Chen IS, Uittenbogaart CH: Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 2007, 14:391-396
15. Zhang L, Kovalev GI, Su L: HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 2007, 109:2978-2981 (Pubitemid 46482096)
16. Sun Z, Denton P, Estes J, Othieno F, Wei B, Wege A, Melkus M, Padgett-Thomas A, Zupancic M, Haase A, Garcia J: Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med 2007, 204:705-714
17. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL, Laouar A, Yao J, Haridas V, Habiro K, Yang YG, Jeong JH, Lee KY, Kim YH, Kim SW, Peipp M, Fey GH, Manjunath N, Shultz LD, Lee SK, Shankar P: T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008, 134:577-586
18. Eden A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslen M: Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis 2007, 196:1779-1783
19. Clifford DB: HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med 2008, 16:94-98
20. Ances BM, Ellis RJ: Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007, 27:86-92 (Pubitemid 46239043)
21. Letendre S, Ances B, Gibson S, Ellis RJ: Neurologic complications of HIV disease and their treatment. Top HIV Med 2007, 15:32-39
22. Jones G, Power C: Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis 2006, 21:1-17
23. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE: Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799
24. Narayan O, Joag SV, Stephens EB: Selected models of HIV-induced neurological disease. Curr Top Microbiol Immunol 1995, 202:151-166
25. Lackner AA, Smith MO, Munn RJ, Martfeld DJ, Gardner MB, Marx PA, Dandekar S: Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol 1991, 139:609-621
26. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, Cornblath DR, Dal Canto MC, DeGirolami U, Dickson D, et al.: HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991, 1:143-152
27. Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE: A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 2009, 64:133-145
28. Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, Adle- Biassette H, Wingertsmann L, Durigon M, Hurtrel B, Chiodi F, Bell J, Lantos P: Neuropathology of early HIV-1 infection. Brain Pathol 1996, 6:1-15
29. An SF, Giometto B, Scaravilli F: HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol 1996, 40:611-617
30. Marcondes MC, Burudi EM, Huitron-Resendiz S, Sanchez-Alavez M, Watry D, Zandonatti M, Henriksen SJ, Fox HS: Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J Immunol 2001, 167:5429-5438
31. McCrossan M, Marsden M, Carnie FW, Minnis S, Hansoti B, Anthony IC, Brettle RP, Bell JE, Simmonds P: An immune control model for viral replication in the CNS during presymptomatic HIV infection. Brain 2006, 129:503-516 (Pubitemid 43164372)
32. Sopper S, Sauer U, Hemm S, Demuth M, Muller J, Stahl-Hennig C, Hunsmann G, ter Meulen V, Dorries R: Protective role of the virusspecific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques. J Virol 1998, 72:9940-9947
33. Williams K, Westmoreland S, Greco J, Ratai E, Lentz M, Kim WK, Fuller RA, Kim JP, Autissier P, Sehgal PK, Schinazi RF, Bischofberger N, Piatak M, Lifson JD, Masliah E, Gonzalez RG: Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest 2005, 115:2534-2545
34. Bissel SJ, Wang G, Trichel AM, Murphey-Corb M, Wiley CA: Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected. CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am J Pathol 2006, 168:1553-1569
35. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860
36. Schmitz JE, Simon MA, Kuroda MJ, Lifton MA, Ollert MW, Vogel CW, Racz P, Tenner-Racz K, Scallon BJ, Dalesandro M, Ghrayeb J, Rieber EP, Sasseville VG, Reimann KA: A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 1999, 154:1923-1932 (Pubitemid 29262876)
37. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998, 72:164-169
38. Sadagopal S, Lorey SL, Barnett L, Basham R, Lebo L, Erdem H, Haman K, Avison M, Waddell K, Haas DW, Kalams SA: Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects. J Virol 2008, 82:10418-10428
39. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B: In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases [published erratum appears in Proc Natl Acad Sci USA: 1993 Jun 1;90(11):5378]. Proc Natl Acad Sci USA 1993, 90:3024-3027
40. Adamson DC, McArthur JC, Dawson TM, Dawson VL: Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS. Mol Med 1999, 5:98-109
41. Lane TE, Buchmeier MJ, Watry DD, Fox HS: Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIVinfected rhesus monkeys: applications to HIV-induced central nervous system disease. Mol Med 1996, 2:27-37 (Pubitemid 3037403)
42. Nuovo G, Alfieri M: AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 1996, 2:358-366
43. Hori K, Burd PR, Furuke K, Kutza J, Weih KA, Clouse KA: Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. Blood 1999, 93:1843-1850
44. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, et al.: Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1988, 167:1428-1441
45. Locardi C, Puddu P, Ferrantini M, Parlanti E, Sestili P, Varano F, Belardelli F: Persistent infection of normal mice with human immunodeficiency virus. J Virol 1992, 66:1649-1654
46. Cota M, Kleinschmidt A, Ceccherini-Silberstein F, Aloisi F, Mengozzi M, Mantovani A, Brack-Werner R, Poli G: Upregulated expression of interleukin-8. RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. J Neurovirol 2000, 6:75-83
47. Cao X, Shores E, Hu-Li J, Anver M, Kelsall B, Russell S, Drago J, Noguchi M, Grinberg A, Bloom E: Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223-238
48. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, et al.: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995, 154:180-191
49. Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI, Dick JE, Danska JS: Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007, 8:1313-1323 (Pubitemid 350138972)
50. Asheuer M, Pflumio F, Benhamida S, Dubart-Kupperschmitt A, Fouquet F, Imai Y, Aubourg P, Cartier N: Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc Natl Acad Sci USA 2004, 101:3557-3562
51. Sopper S, Koutsilieri E, Scheller C, Czub S, Riederer P, ter Meulen V: Macaque animal model for HIV-induced neurological disease. J Neural Transm 2002, 109:747-766
52. Veazey RS, Acierno PM, McEvers KJ, Baumeister SH, Foster GJ, Rett MD, Newberg MH, Kuroda MJ, Williams K, Kim EY, Wolinsky SM, Rieber EP, Piatak M Jr, Lifson JD, Montefiori DC, Brown CR, Hirsch VM, Schmitz JE: Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys. J Virol 2008, 82:5618-5630
53. Berman NE, Sheffield LG, Purcell J, Joag SV, Narayan O, Cheney P: Gradient of microglial activation in the brain of SIV infected macaques. J NeuroAIDS 1998, 2:43-54
54. Nebuloni M, Pellegrinelli A, Ferri A, Tosoni A, Bonetto S, Zerbi P, Boldorini R, Vago L, Costanzi G: Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndrome. J NeuroVirol 2000, 6:46-50 (Pubitemid 30175572)
55. Lisak RP, Benjamins JA, Bealmear B, Nedelkoska L, Studzinski D, Retland E, Yao B, Land S: Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures. J Neuroinflammation 2009, 6:4
56. Bukrinsky MI, Nottet HS, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE: Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV- associated neurological disease. J Exp Med 1995, 181:735-745
57. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL: Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917-1921
58. Brown GC: Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 2007, 35:1119-1121
59. Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC: Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc Natl Acad Sci USA 2008, 105:15511-15516
60. Phares TW, Kean RB, Mikheeva T, Hooper DC: Regional Differences in Blood-Brain Barrier Permeability Changes and Inflammation in the Apathogenic Clearance of Virus from the Central Nervous System. J Immunol 2006, 176:7666-7675
61. An SF, Scaravilli F: Early HIV-1 infection of the central nervous system. Arch Anat Cytol Pathol 1997, 45:94-105
62. Avgeropoulos N, Kelley B, Middaugh L, Arrigo S, Persidsky Y, Gendelman HE, Tyor WR: SCID mice with HIV encephalitis develop behavioral abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:13-20 (Pubitemid 128703583)
63. Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Liu XJ, Stins M, Fiala M, Way D, Kim KS, Witte MH, Weinand M, Carhart L, Gendelman HE: Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999, 155:1599-1611
64. Zelivyanskaya ML, Nelson JA, Poluektova L, Uberti M, Mellon M, Gendelman HE, Boska MD: Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J Neurosci Res 2003, 73:284-295
65. Nukuna A, Gendelman HE, Limoges J, Rasmussen J, Poluektova L, Ghorpade A, Persidsky Y: Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis. J Neurovirol 2004, 10 Suppl 1:82-90
66. Peng H, Erdmann N, Whitney N, Dou H, Gorantla S, Gendelman HE, Ghorpade A, Zheng J: HIV-1-infected and/or immune activated macophages regulate astrocyte SDF-1 production through IL-1beta. Glia 2006, 54:619-629
67. Sas AR, Bimonte-Nelson H, Smothers CT, Woodward J, Tyor WR: Interferon-{alpha} causes neuronal dysfunction in encephalitis. J Neurosci 2009, 29:3948-3955
68. Limoges J, Persidsky Y, Bock P, Gendelman HE: Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice. J Infect Dis 1997, 175:1368-1381 (Pubitemid 27225040)
69. Limoges J, Persidsky Y, Poluektova L, Rasmussen J, Ratanasuwan W, Zelivyanskaya M, McClernon DR, Lanier ER, Gendelman HE: Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice. Neurology 2000, 54:379-389
70. Masliah E, DeTeresa RM, Mallory ME, Hansen LA: Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000, 14:69-74
71. Michaels J, Sharer LR, Epstein LG: Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodefic Rev 1988, 1:71-104
72. Li CM, Lee YY, Ho YR: Acute meningoencephalitis as initial presentation of human immunodeficiency virus infection: report of two cases. J Microbiol Immunol Infect 2002, 35:195-198
73. Barnes CA: Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 1979, 93:74-104
74. Markowska AL, Stone WS, Ingram DK, Reynolds J, Gold PE, Conti LH, Pontecorvo MJ, Wenk GL, Olton DS: Individual differences in aging: behavioral and neurobiological correlates. Neurobiol Aging 1989, 10:31-43
75. Sjoo F, Hassan Z, Abedi-Valugerdi M, Griskevicius L, Nilsson C, Remberger M, Aschan J, Concha H, Gaughan U, Hassan M: Myeloablative and immunosuppressive properties of treosulfan in mice. Exp Hematol 2006, 34:115-121
76. Ishikawa F, Livingston AG, Wingard JR, Nishikawa S, Ogawa M: An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice. Exp Hematol 2002, 30:488-494
77. Czechowicz A, Kraft D, Weissman IL, Bhattacharya D: Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 2007, 318:1296-1299 (Pubitemid 350172893)
78. Lien E, Aukrust P, Sundan A, Muller F, Froland SS, Espevik T: Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 1998, 92:2084-2092
79. Pandrea I, Gaufin T, Brenchley JM, Gautam R, Monjure C, Gautam A, Coleman C, Lackner AA, Ribeiro RM, Douek DC, Apetrei C: Cutting edge: experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. J Immunol 2008, 181:6687-6691
80. Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D: Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 2008, 3:e2516
81. Limoges J, Poluektova L, Ratanasuwan W, Rasmussen J, Zelivyanskaya M, McClernon DR, Lanier ER, Gendelman HE, Persidsky Y: The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis. Virology 2001, 281:21-34
82. Dou H, Birusingh K, Faraci J, Gorantla S, Poluektova LY, Maggirwar SB, Dewhurst S, Gelbard HA, Gendelman HE: Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 2003, 23:9162-9170
83. Dou H, Ellison B, Bradley J, Kasiyanov A, Poluektova LY, Xiong H, Maggirwar S, Dewhurst S, Gelbard HA, Gendelman HE: Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. J Neurosci 2005, 25:8375-8385
84. Gorantla S, Liu J, Wang T, Holguin A, Sneller HM, Dou H, Kipnis J, Poluektova L, Gendelman HE: Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis. Glia 2008, 56:223-232
85. Eggert D, Dash PK, Serradji N, Dong CZ, Clayette P, Heymans F, Dou H, Gorantla S, Gelbard HA, Poluektova L, Gendelman HE: Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders. J Neuroimmunol 2009, 213:47-59
86. Eggert D, Dash PK, Gorantla S, Dou H, Schifitto G, Maggirwar SB, Dewhurst S, Poluektova L, Gelbard HA, Gendelman HE: Neuroprotective activities of CEP-1347 in models of neuroAIDS. J Immunol 2010, 184:746-756
87. Gorantla S, Liu J, Sneller H, Dou H, Holguin A, Smith L, Ikezu T, Volsky DJ, Poluektova L, Gendelman HE: Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis. J Immunol 2007, 179:4345-4356
88. Potula R, Haorah J, Knipe B, Leibhart J, Chrastil J, Heilman D, Dou H, Reddy R, Ghorpade A, Persidsky Y: Alcohol Abuse Enhances Neuroinflammation and Impairs Immune Responses in an Animal Model of Human Immunodeficiency Virus-1 Encephalitis. Am J Pathol 2006, 168:1335-1344
89. Potula R, Poluektova L, Knipe B, Chrastil J, Heilman D, Dou H, Takikawa O, Munn DH, Gendelman HE, Persidsky Y: Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood 2005, 106:2382-2390
90. Gorantla S, Markarov E, Roy D, Finke-Dwyer J, Murrin LC, Gendelman HE, Poluektova L: Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS. J Neuroimmune Pharmacol 2010, 5:456-468